Literature DB >> 11401564

The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro.

L H Nguyen1, L Espert, N Mechti, D M Wilson.   

Abstract

The human ISG20/HEM45 gene was identified independently on the basis of its increased level of expression in response to either interferon or estrogen hormone. Notably, the encoded protein is homologous with members of the 3' to 5' exonuclease superfamily that includes RNases T and D, and the proofreading domain of Escherichia coli DNA polymerase I. We provide here direct biochemical evidence that Isg20 acts as a 3' to 5' exonuclease in vitro. This protein displays a pH optimum of approximately 7.0, prefers Mn2+ as a metal cofactor, and degrades RNA at a rate that is approximately 35-fold higher than its rate for single-stranded DNA. Along with RNase L, Isg20 is the second known RNase regulated by interferon. Previous data showed that Isg20 is located in promyelocytic leukemia (PML) nuclear bodies, known sites of hormone-dependent RNA polymerase II transcription and oncogenic DNA viral transcription and replication. The combined data suggest a potential role for Isg20 in degrading viral RNAs as part of the interferon-regulated antiviral response and/or cellular mRNAs as a regulatory component of interferon and estrogen signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401564     DOI: 10.1021/bi010141t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.

Authors:  Dong Jiang; Jessica M Weidner; Min Qing; Xiao-Ben Pan; Haitao Guo; Chunxiao Xu; Xianchao Zhang; Alex Birk; Jinhong Chang; Pei-Yong Shi; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts.

Authors:  Tao Peng; Jia Zhu; Yon Hwangbo; Lawrence Corey; Roger E Bumgarner
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

Review 3.  Interferon-stimulated gene 20-kDa protein (ISG20) in infection and disease: Review and outlook.

Authors:  Zhiwei Zheng; Lin Wang; Jihong Pan
Journal:  Intractable Rare Dis Res       Date:  2017-02

4.  Estradiol and proinflammatory cytokines stimulate ISG20 expression in synovial fibroblasts of patients with osteoarthritis.

Authors:  Zhiwei Zheng; Lin Wang; Jihong Pan
Journal:  Intractable Rare Dis Res       Date:  2017-11

Review 5.  Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Authors:  Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

6.  Influenza A Virus-induced expression of ISG20 inhibits viral replication by interacting with nucleoprotein.

Authors:  Hongren Qu; Jing Li; Limin Yang; Lei Sun; Wenjun Liu; Hongxuan He
Journal:  Virus Genes       Date:  2016-06-24       Impact factor: 2.332

7.  Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.

Authors:  Michelle Mendenhall; Min-Hui Wong; Ramona Skirpstunas; John D Morrey; Brian B Gowen
Journal:  Virology       Date:  2009-09-26       Impact factor: 3.616

8.  Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.

Authors:  Dong Jiang; Haitao Guo; Chunxiao Xu; Jinhong Chang; Baohua Gu; Lijuan Wang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

Review 9.  Innate immune responses in hepatitis C virus infection.

Authors:  Kui Li; Stanley M Lemon
Journal:  Semin Immunopathol       Date:  2012-08-07       Impact factor: 9.623

10.  Host Interferon-Stimulated Gene 20 Inhibits Pseudorabies Virus Proliferation.

Authors:  Xiaoyong Chen; Dage Sun; Sujie Dong; Huanjie Zhai; Ning Kong; Hao Zheng; Wu Tong; Guoxin Li; Tongling Shan; Guangzhi Tong
Journal:  Virol Sin       Date:  2021-04-08       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.